SiModecs is a joint Venture operation with Sibiono and Modecs Genetics from Canada. We are a joint operation between the Sibiono with a really excellent product Gendicine for cancer tumour treatment and Modecs Genetics focus in further market development of Gendicine globally. Modecs Genetics will continue to further development of Gendicine with biomarker program to enhance the cancer treatment and effectiveness for our patient. SiModecs vision is to provide the latest cancer treatment regiment to our cancer patients and this will enhance and improve the quality of their life..